<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="72216">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01942642</url>
  </required_header>
  <id_info>
    <org_study_id>4-2012-0690</org_study_id>
    <nct_id>NCT01942642</nct_id>
  </id_info>
  <brief_title>Evaluation of Dry Eye and Meibomian Gland Dysfunction After Cataract Surgery</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Yonsei University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Yonsei University</source>
  <oversight_info>
    <authority>Korea: Institutional Review Board</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Meibomian gland dysfunction (MGD) is a common and important disease has been investigated
      the pathophysiology, diagnosis, treatment modalities of MGD, however, the changes of MGD
      after the cataract surgery, the most popular surgery to ophthalmologist, had not been
      evaluated. The investigators evaluated parameters related with MGD including lid margin
      abnormalities, meibomian gland expressibility and meibography before and after surgery.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>November 2012</start_date>
  <completion_date type="Actual">April 2013</completion_date>
  <primary_completion_date type="Actual">April 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model: Case-Only, Time Perspective: Prospective</study_design>
  <primary_outcome>
    <measure>Ocular parameters</measure>
    <time_frame>change of Ocular parameters  from 1 to 3 months after cataract surgery</time_frame>
    <safety_issue>No</safety_issue>
    <description>Ocular symptom score, lid margin abnormalities, superficial punctuate keratopathy, tear film break-up time, Shirmer's test, lower tear meniscus height (TMH), depth (TMD), and area (TMA), meibum expressibility, and meibography score</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">48</enrollment>
  <condition>Meibomian Gland Dysfunction</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Patients scheduled for cataract surgery
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

        1. Patients scheduled for cataract surgery

        Exclusion Criteria:

          1. other comorbid ocular diseases such as ocular allergies.

          2. continuous use of topical ocular medications before surgery

          3. histories of ocular surgery, or ocular injury

          4. Already had severe obstructive MGD before surgery, abnormal findings on lid margin (&gt;
             3 positive findings), reduced meibum expression (&gt; grade 2), and obstructed gland
             dropout (meibography score &gt; 3)
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>45 Years</minimum_age>
    <maximum_age>88 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <verification_date>September 2013</verification_date>
  <lastchanged_date>September 13, 2013</lastchanged_date>
  <firstreceived_date>August 29, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>cataract surgery, meibomian gland dysfunction, meibum expressibility, meibography</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
